Abstract:BACKGROUND:Vascular homeostasis is maintained by the differentiated phenotype of vascular smooth muscle cells (VSMCs). The landscape of protein coding genes comprising the transcriptome of differentiated VSMCs has been intensively investigated but many gaps remain including the emerging roles of noncoding genes.METHODS:We reanalyzed large-scale, publicly available bulk and single-cell RNA sequencing datasets from multiple tissues and cell types to identify VSMC-enriched long noncoding RNAs. The in vivo expression pattern of a novel smooth muscle cell (SMC)-expressed long noncoding RNA, Carmn (cardiac mesoderm enhancer-associated noncoding RNA), was investigated using a novel Carmn green fluorescent protein knock-in reporter mouse model. Bioinformatics and quantitative real-time polymerase chain reaction analysis were used to assess CARMN expression changes during VSMC phenotypic modulation in human and murine vascular disease models. In vitro, functional assays were performed by knocking down CARMN with antisense oligonucleotides and overexpressing Carmn by adenovirus in human coronary artery SMCs. Carotid artery injury was performed in SMC-specific Carmn knockout mice to assess neointima formation and the therapeutic potential of reversing CARMN loss was tested in a rat carotid artery balloon injury model. The molecular mechanisms underlying CARMN function were investigated using RNA pull-down, RNA immunoprecipitation, and luciferase reporter assays.RESULTS:We identified CARMN, which was initially annotated as the host gene of the MIR143/145 cluster and recently reported to play a role in cardiac differentiation, as a highly abundant and conserved, SMC-specific long noncoding RNA. Analysis of the Carmn GFP knock-in mouse model confirmed that Carmn is transiently expressed in embryonic cardiomyocytes and thereafter becomes restricted to SMCs. We also found that Carmn is transcribed independently of Mir143/145. CARMN expression is dramatically decreased by vascular disease in humans and murine models and regulates the contractile phenotype of VSMCs in vitro. In vivo, SMC-specific deletion of Carmn significantly exacerbated, whereas overexpression of Carmn markedly attenuated, injury-induced neointima formation in mouse and rat, respectively. Mechanistically, we found that Carmn physically binds to the key transcriptional cofactor myocardin, facilitating its activity and thereby maintaining the contractile phenotype of VSMCs.CONCLUSIONS:CARMN is an evolutionarily conserved SMC-specific long noncoding RNA with a previously unappreciated role in maintaining the contractile phenotype of VSMCs and is the first noncoding RNA discovered to interact with myocardin.

Long noncoding RNAs C2dat1 enhances vascular smooth muscle cell proliferation and migration by targeting MiR‐34a‐5p

Discovery of an Evolutionarily Conserved Smooth Muscle Cell-Specific Lncrna CARMN

Discovery of an evolutionarily conserved smooth muscle cell-specific lncRNA<i>CARMN</i>

CARMN is an Evolutionarily Conserved Smooth Muscle Cell-Specific LncRNA That Maintains Contractile Phenotype by Binding Myocardin

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition

LINC01123 Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells and Alleviates Carotid Atherosclerosis by Modulating miR-1277-5p/KLF5

Long non‐coding RNA AL355711 promotes smooth muscle cell migration through the ABCG1/MMP3 pathway

Role of Hsa_circ_0000280 in Regulating Vascular Smooth Muscle Cell Function and Attenuating Neointimal Hyperplasia Via ELAVL1

Long non-coding RNA C2dat1 regulates CaMKIIδ expression to promote neuronal survival through the NF-κB signaling pathway following cerebral ischemia

LncRNA TNK2-AS1 Regulated Ox-Ldl-stimulated HASMC Proliferation and Migration Via Modulating VEGFA and FGF1 Expression by Sponging Mir-150-5p

LncRNA CDKN2B-AS1 hinders the proliferation and facilitates apoptosis of ox-LDL-induced vascular smooth muscle cells via the ceRNA network of CDKN2B-AS1/miR-126-5p/PTPN7

Circ_0006251 mediates the proliferation and apoptosis of vascular smooth muscle cells in CAD via enhancing TET3 and PPM1B expression

Long noncoding RNA ZNF800 suppresses proliferation and migration of vascular smooth muscle cells by upregulating PTEN and inhibiting AKT/mTOR/HIF-1α signaling

Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis

LINC00472 regulates vascular smooth muscle cell migration and proliferation via regulating miR-149-3p

miR-654-5p suppresses migration and proliferation of vascular smooth muscle cells by targeting ADAMTS-7.

CDKN2B-AS1 Mediates Proliferation and Migration of Vascular Smooth Muscle Cells Induced by Insulin.

LINC01123 promotes cell proliferation and migration via regulating miR-1277-5p/KLF5 axis in ox-LDL-induced vascular smooth muscle cells

LncRNA-RP11-714G18.1 Suppresses Vascular Cell Migration Via Directly Targeting LRP2BP

Circ_0002984 Induces Proliferation, Migration and Inflammation Response of VSMCs Induced by Ox‐ldl Through Mir‑326‐3p/vamp3 Axis in Atherosclerosis

Long non-coding RNAs: Modulators of phenotypic transformation in vascular smooth muscle cells